Publications

    Peer-reviewed journals (most recent first; *Corresponding author)

    1. Khan S, Kumar Y, Sharma C, Gupta SK, Goel A, Aggarwal R, Veerapu NS. Dysregulated metabolites and lipids in serum of patients with acute hepatitis E: A longitudinal study. J Viral Hepat. 2023 Sep 11. doi: 10.1111/jvh.13885. Epub ahead of print. PMID: 37697495.
    2. Goel A*, Katiyar H, Mayank, Tiwari P, Rungta S, Verma A, Deep A, Sana A, Rai P, Aggarwal R. Hepatitis C retreatment with first-line direct acting antiviral drugs. J Clin Exp Hepatol. 2023 Sep-Oct;13(5):736-741.
    3. Kumar, Pankaj; Singh, Thakur Prashant; Aggarwal, Amita1; Rai, Praveer; Goel, Amit*. Fresh-Frozen Plasma as a Low-Cost Replacement of Intravenous Immunoglobulin for the Treatment of Symptomatic Hypogammaglobulinemia. Journal of Emergencies, Trauma, and Shock: DOI: 10.4103/jets.jets_36_23
    4. Lazarus JV, Han H, Mark HE, Alqahtani SA, Schattenberg JM, Soriano JB, White TM, Zelber-Sagi S, Dirac MA; GBD Fatty Liver Disease Sustainable Development Goal Collaborators. The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories. Hepatology. 2023;78(3):911-928.
    5. Vaishnav M, Biswas S, Anand A, Pathak P, Swaroop S, Aggarwal A, Arora U, Elhence A, Gamanagatti S, Goel A, Kumar R, Shalimar. Hepatic Venous Pressure Gradient Predicts Further Decompensation in Cirrhosis Patients with Acute Esophageal Variceal Bleeding. Diagnostics (Basel). 2023 Jul 16;13(14):2385.
    6. Biswas S, Vaishnav M, Farooqui N, Aggarwal A, Pathak P, Yadav R, Das P, Elhence A, Goel A, Mishra AK, Shalimar. Impact of body mass index on disease progression and outcomes in patients with nonalcoholic fatty liver disease. Postgrad Med J. 2023 Jun 12:qgad035. doi: 10.1093/postmj/qgad035. Epub ahead of PMID: 37308443.
    7. Katiyar H, Tiwari P, Bhadauria DS, Rai P, Goel A*. Rescue use of Pegylated Interferon in Dialysis Patient who Failed to Respond Sofosbuvir. Indian J 2023 Mar-Apr;33(2):152-154.
    8. Awasthi A, Katiyar H, Rungta S, Deep A, Kumar V, Shalimar, Kumar A, Tiwari P, Goel A*. Eight versus twelve weeks of sofosbuvir-velpatasvir in treatment-naïve non-cirrhotic patients with chronic hepatitis C virus infection: Study protocol for a multicentric, open labelled, randomized, non-inferiority trial (RESOLVE trial). PLoS One. 2023 May 18;18(5):e0285725. doi: 10.1371/journal.pone.0285725
    9. Rai P, Majeed A, Kumar P, Rajput M, Goel A, Rao RN. Endoscopic ultrasound-guided liver biopsy using a single-pass, slow-pull technique with a 19-G Franseen tip fine-needle biopsy needle: A prospective study. Indian J Gastroenterol. 2023 Apr 25. doi: 10.1007/s12664-023-01339-7. Epub ahead of print. PMID: 37097513.
    10. Patwa AK, deep A, Atam V, Mishra P, Rungta S, Gangwar A, Yadav A, Gupta KK, Agrawal B, Verma SK, Goel A. KGHeBTA (King George’s Medical University Hepatitis B Therapeutic Algorithm): A new diagnostic and therapeutic algorithm and clinico-epidemiological spectrum of hepatitis B.J Clin Exp Hepatol. 2023 Jul-Aug;13(4):629-637
    11. Bhadauria DS, Tiwari P, Goel A*, Katiyar H, Kaul A, Mayank, Aggarwal A, Verma A, Khetan D, Yachha M, Behera MR, Yadav B, Agarwal K, Prasad N. Antibody response to ChAdOx1 nCoV-19 (Covishield®) vaccine in people on maintenance hemodialysis. Semin Dial. 2023 Feb 26. doi: 10.1111/sdi.13149. Epub ahead of print. PMID: 36843062
    12. Goel A, Lalruatsanga D, Himanshu D, Bharti V, Sharma D. Acute Liver Failure Prognostic Criteria: It's Time to Revisit. Cureus. 2023 Jan 16;15(1):e33810
    13. Rajak S, Tewari A, Raza S, Gupta P, Chakravarti B, Anjum B, Tripathi M, Singh BK, Yen PM, Goel A, Ghosh S, Sinha RA. Pharmacological inhibition of CFTR attenuates nonalcoholic steatohepatitis (NASH) progression in mice. BiochimBiophys Acta Mol Basis Dis. 2023 Apr;1869(4):166662
    14. Tripathi SK, Pal A, Ghosh S, Goel A, Aggarwal R, Banerjee S, Das S. LncRNA NEAT1 regulates HCV-induced Hepatocellular carcinoma by modulating the miR-9-BGH3 axis. J Gen Virol. 2022 Dec;103(12).
    15. Rai P, Kumar P, Goel A, Singh TP, Sharma M. Naso-jejunal tube-assisted endoscopic ultrasound-guided gastrojejunostomy for the management of gastric outlet obstruction is safe and effective. DEN Open. 2023 Jan 30;3(1):e210.
    16. Verma A, Goel A*, Katiyar H, Tiwari P, Mayank, Sana A, Khetan D, Bhadauria DS, Raja A, Khokher N, Shalimar, Singh RK, Aggarwal A. Durability of ChAdOx1 nCoV-19 (Covishield®) Vaccine Induced Antibody Response in Health Care Workers. Vaccines (Basel). 2022 Dec 30;11(1):84.
    17. Dandu H, Kumar V, Goel A, Khetan D, Chandra T, Bharti VR. A preliminary experience of plasma exchange in liver failure. Asian J Transfus Sci 2022; 16:209-13.
    18. Goel A*, Verma A, Tiwari P, Katiyar H, Aggarwal A, Khetan D, Mayank, Kishore RVK, Kumar P, Singh TP, Sheikh S, Vaishnav M, Pathak P, Shalimar. Serological Immune Response Following ChAdOx1 nCoV-19 Vaccine (Covishield®) in Patients with Liver Cirrhosis. Vaccines. 2022; 10(11):1837.
    19. Bhadauria DS, Katiyar H, Goel A*, Tiwari P, Kishore RVK, Aggarwal A, Verma A, Khetan D, Kaul A, Yachha M, Behera MR, Yadav B, Prasad N. Antibody Response to ChAdOx1 nCoV-19 (AZD1222) Vaccine in Kidney Transplant Recipients. Vaccines. 2022; 10(10):1693.
    20. Pradhan A, Shivaprasad S, Dey S, Goel A, Aggarwal R, Das S. (2022). Exosome-associated microRNA-375 induces cell proliferation by regulating IGFBP4 upon hepatitis C virus infection. Molecular Microbiology. 2-22; 118: 570– 587.
    21. GBD 2019 Cancer Risk Factors Collaborators. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2022 Aug 20;400(10352):563-591.
    22. Ghosh NK, Singh A, Rahul, Singh RK, Goel A, Saxena R. Multifocal Small Bowel Angioectasias: Managed with Innovative, Non-resectional Surgical Procedure. Surg J (NY) 2022;8:e169–e173
    23. GBD 2020 Alcohol Collaborators. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020. Lancet. 2022 Jul 16;400(10347):185-235.
    24. GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol 2022 Sep;7(9):796-829
    25. Sharma H, Bhadauria D, Goel A, Yaccha M, Gurjar M, Kaul A, Veeranki V, Shamungham S, Jain M, Mohindra S, Prasad N. Co-existence of acute pancreatitis with hemolytic uremic syndrome: "The dilemma of a rare organ cross-talk". Pancreatology. 2022;22(6):823-825.
    26. Shalimar, Priya S, Gupta H, Bansal B, Elhence A, Krishna Kishore RV, Goel A*. A systematic review of risk factors for hepatitis C virus infection among low-risk population in India. J Clin Exp Hepatol 2022;12 (6): 1438-44.
    27. Bhadauria DS, Kumar P, Tiwari P, Kaul A, Negi TS, Rai P, Shanmugam S, Veeranki V, Prasad N, Goel A*. Liver stiffness is reduced to normal after successful renal transplantation: A prospective cohort study. J Clin Exp Hepatol 2022;12 (6): 1445-50.
    28. Goel A, Rewari BB, Sharma M, Konath NM, Aggarwal R. Seroprevalence and burden of hepatitis C virus infection in WHO South-East Asia Region (SEAR): A systematic review. J Gastroenterol Hepatol 2022; 37: 964– 972.
    29. Mundada K, Goel A, Paliwal VK, Singh TP, Rai P, Aggarwal R. Short course of low-dose pregabalin is effective for the treatment of restless leg syndrome in patients with cirrhosis: A pilot study. J Gastroenterol Hepatol. 2022;37(5):933-937.
    30. GBD 2019 Adolescent and Young Adult Cancer Collaborators. The global burden of adolescent and young adult cancer in 2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Oncol. 2022 Jan;23(1):27-52
    31. Vaishnav M, Elhence A, Biswas S, Pathak P, Anand A, Sheikh S, Singh V, Maitra S, Goel A, Shalimar. The Outcome in Cirrhosis after Hospital Discharge is Not Worsened with COVID-19 Infection: A Propensity Score-matched Analysis. J Clin Exp Hepatol. 2022;12(3):830-840.
    32. Shalimar, Elhence A, Bansal B, Gupta H, Anand A, Singh TP, Goel A*. Prevalence of non-alcoholic fatty liver disease in India: A systematic review and meta-analysis. J Clin Exp Hepatol 2022;12 (3):818–829.
    33. Elhence A, Vaishnav M, Biswas S, Anand A, Gunjan D, Kedia S, Mahapatra SJ, Nayak B, Sheikh S, Soni KD, Trikha A, Goel A, Shalimar. Predictors of in-hospital Outcomes in Patients with Cirrhosis and Coronavirus Disease-2019. J Clin Exp Hepatol. 2022;12(3):876-886
    34. Aggarwal R, Goel A. Hepatitis E: Current Status in India. Clinical Liver Disease 2021; 18: 168-172.
    35. Chhavi N, Ojha S, Awasthi A, Shalimar, Goel A*. Serum level of alanine- and aspartate-aminotransferase levels in newborns in India. J Clin Exp Hepatol 2022; 12 (2):306–311.
    36. Yadav S, Goel A, Lingaiah R, Pradhan M, Katiyar H, Aggarwal R. Serum bile acid levels in women with intrahepatic cholestasis of pregnancy in India. J Clin Exp Hepatol 2022; 12 (2): 379–383.
    37. Tiwari P, Katiyar H, Rai P, Goel A*. Use of Sofosbuvir/Velpatasvir/Voxilaprevir for Sofosbuvir non-responder genotype 3 HCV infection in India. J Clin Exp Hepatol 2022; 12 (2): 669-671
    38. Rai P, Harish KC, Majeed A, Goel A. EUS-guided drainage of pancreatic fluid collection, using a modified technique of cystotome alone without a FNA needle. Saudi J Gastroenterol. 2021; 27(5):283-88.
    39. GBD 2019 Under-5 Mortality Collaborator. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019. Lancet. 2021 Sep 4;398(10303):870-905.
    40. Srivastava G, Chhavi N, Shamsi S, Goel A, Bhatnagar S. Generalized Anxiety Disorder and Associated Factors among Indian Pediatricians during the Coronavirus Disease 2019 Outbreak: A Web-based Cross-sectional Survey. J Med Sci Health 2021;7(1):9-15
    41. Goel A, Bhadauria DS, Kaul A, Verma A, Tiwari P, Rungta S, Rai P, Gupta A, Aggarwal R. Acute hepatitis C treatment in advanced renal failure using 8 weeks of pan-genotypic daclatasvir and reduced-dose sofosbuvir. Nephrol Dial Transplant. 2021; 36(10):1867-71.
    42. Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol. 2021 Jan-Feb;11(1):97-143.
    43. Goel A, Rungta S, Verma P, Verma A, Verma AN, Rai P, Aggarwal R. Viral suppression is comparable with 0.5 mg and 1.0 mg daily doses of entecavir in treatment-naive HBV-related decompensated cirrhosis. Antivir Ther. 2020;25(5):267-273.
    44. Goel A, Aggarwal R. Hepatitis E: Epidemiology, Clinical Course, Prevention, and Treatment. Gastroenterol Clin North Am. 2020 Jun;49(2):315-330.
    45. Halkurike VJ, Goel A, Katiyar H, Agarwal SK, Pande S, Aggarwal R. Blood transfusion is unlikely to be a source for hepatitis E virus transmission in India. Indian J Gastroenterol. 2020;39(2):161-164
    46. Goel A, Padmaprakash KV, Benjamin M, Katiyar H, Aggarwal R. Temporal profile of HEV RNA concentration in blood and stool from patients with acute uncomplicated hepatitis E in a region with genotype 1 predominance. J Viral Hepat. 2020 Jun;27(6):631-637.
    47. Bhadauria D, Thammishetti V, Goel A, Kaul A, Kushwah RS, Behera M, Gupta A, Prasad N. An Analysis of Epidemiology, Etiology, and Outcomes of Acute Pancreatitis in Renal Transplant Recipients. Transplant Proc. 2020;52(3):865-872.
    48. Goel A, Vijay HJ, Katiyar H, Aggarwal R. Prevalence of hepatitis E viraemia among blood donors: a systematic review. Vox Sang. 2020;115(3):120-132.
    49. Ghoshal UC, Goel A, Quigley EMM. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. Indian J Gastroenterol. 2020 Feb;39(1):9-21.
    50. Halkurike-Jayadevappa VK, Goel A, Paliwal VK, Rai P, Aggarwal R. Liver disease severity is poorly related to the presence of restless leg syndrome in patients with cirrhosis. Neurol India 2019; 67:732-7
    51. Srijithesh PR, Aghoram R, Goel A, Dhanya J. Positional therapy for obstructive sleep apnoea. Cochrane Database of Systematic Reviews 2019, Issue 5. Art. No.: CD010990.
    52. Aggarwal R, Goel A. Natural History, Clinical Manifestations, and Pathogenesis of Hepatitis E Virus Genotype 1 and 2 Infections. Cold Spring Harb Perspect Med. 2019 Jul 1;9(7).
    53. Goel A, Seguy N, Aggarwal R. Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2019 Feb;34(2):321-329
    54. Goel A, Bhadauria DS, Kaul A, Verma P, Mehrotra M, Gupta A, Sharma RK, Rai P, Aggarwal R. Daclatasvir and reduced dose sofosbuvir: an effective and pangenotypic treatment for hepatitis C in patients with eGFR <30 ml/min. Nephrology (Carlton). 2019; 24: 316-21.
    55. Sarangi AN, Goel A, Aggarwal R. Methods for Studying Gut Microbiota: A Primer for Physicians. J Clin Exp Hepatol 2019; 9: 62–73.
    56. Goel A, Bhadauria DS, Aggarwal R. Hepatitis C virus infection and chronic renal disease: A review. Indian J Gastroenterol. 2018; 37: 492-503.
    57. Goel A, Chen Q, Chhatwal J, Aggarwal R. Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment. J Gastroenterol Hepatol. 2018 Dec;33(12):2029-2036
    58. Shwetha S, Sharma G, Raheja H, Goel A, Aggarwal R, Das S. Interaction of miR-125b-5p with Human antigen R mRNA: mechanism of controlling HCV replication. Virus Res. 2018 Oct 15; 258:1-8.
    59. Srivastava G, Chhavi N, Goel A. Validation of Serum Aminotransferases Levels to Define Severe Dengue Fever in Children. Pediatr Gastroenterol Hepatol Nutr. 2018 Oct;21(4):289-296.
    60. Katiyar H, Goel A, Sonker A, Yadav V, Sapun S, Chaudhary R, Aggarwal R. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India. Indian J Gastroenterol. 2018; 37(4): 342-346.
    61. Rai P, KC Harish, Goel A, Aggarwal R, Sharma M. Endoscopic ultrasound-guided coil and glue for treatment of splenic artery pseudo-aneurysm: new kid on the block! Endosc Int Open. 2018 Jul;6 (7): E821-E825.
    62. Singh A, Sarangi AN, Goel A, Srivastava R, Bhargava R, Gaur P, Aggarwal A, Aggarwal R. Effect of administration of a probiotic preparation on gut microbiota and immune response in healthy women in India: an open-label, single-arm pilot study. BMC Gastroenterol. 2018 Jun 15;18(1):85.
    63. Sharma B, Katiyar H, Barall D, Sharma N, Agnihotry S, Goel A, Aggarwal R. Genotyping of hepatitis B virus isolates from Lahaul and Spiti district in Himachal Pradesh, India. Indian J Gastroenterol. 2018 May;37(3):261-265
    64. Prasad N, Patel M R, Pandey A, Jaiswal A, Bhadauria D, Kaul A, Sharma R K, Mohindra S, Pandey G, Goel A, Gupta A. Direct-acting antiviral agents in Hepatitis C Virus-infected renal allograft recipients: Treatment and outcome experience from single center. Indian J Nephrol 2018; 28: 220-5
    65. Rai P, Lokesh CR, Goel A, Aggarwal R. Endoscopic ultrasound-guided choledochoduodenostomy using partially-covered self-expandable metal stent in patients with malignant distal biliary obstruction and unsuccessful ERCP. Endoscopy International Open 2018; 06: E67–E72
    66. Gupta N, Sarangi AN, Dadhich S, Dixit VK, Chetri K, Goel A, Aggarwal R. Acute hepatitis E in India appears to be caused exclusively by genotype 1 hepatitis E virus. Indian J Gastroenterol. 2018; 37: 44-49.
    67. Sarangi AN, Goel A, Singh A, Sasi A, Aggarwal R. Faecal bacterial microbiota in patients with cirrhosis and the effect of lactulose administration. BMC Gastroenterol. 2017; 17(1):125.
    68. Goel A, Bakshi SS, Soni N, Chhavi N. Iron deficiency anemia and Plummer–Vinson syndrome: current insights. Journal of Blood Medicine 2017, 8:175-184.
    69. Goel A, Bhargava R, Rai P, Aggarwal R. Treatment of chronic genotype-3 hepatitis C virus infection using direct-acting antiviral agents: An Indian experience. Indian J Gastroenterol 2017; 36 (3): 227–234
    70. Goel A, Arivazhagan K, Sasi A, Shanmugam V, Koshi S, Pottakkat B, Lakshmi CP, Awasthi A. Translation and validation of chronic liver disease questionnaire (CLDQ) in Tamil language. Indian J Gastroenterol. 2017; 36(3), 217-226.
    71. Aggarwal R, Chen Q, Goel A, Seguy N, Pendse R, Ayer T, Chhatwal J. Cost-effectiveness of hepatitis C treatment using generic direct-acting antivirals available in India.PLoS One. 2017 May 17;12(5): e0176503.
    72. Goel A, Bhadauria DS, Kaul A, Prasad N, Gupta A, Sharma RK, Rai P, Aggarwal R. Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients. Indian J Gastroenterol. 2017; 36 (2): 137-140.
    73. Goel A, Bhadauria DS, Kaul A, Prasad N, Gupta A, Sharma RK, Rai P, Aggarwal R. Safety and effectiveness of response-guided therapy using pegylated interferon and ribavirin for chronic hepatitis C virus infection in patients on maintenance dialysis. Nephrology (Carlton). 2017 Sep;22(9):706-711.
    74. Mukta V, Panicker LC, Sivamani K, Goel A, Basu D, Dhanapathi H. Non-cirrhotic portal fibrosis at a tertiary care centre in South India. Trop Doct. 2017 Jan;47(1):26-30.
    75. Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Sarin SK, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S. Indian National Association for Study of the Liver (INASL) Guidance for antiviral therapy against HCV infection: Update 2016. J Clin Exp Hepatol. 2016 Jun;6(2):119-45.
    76. Goel A, Jat SL, Sasi A, Paliwal VK, Aggarwal R. Prevalence, severity, and impact on quality of life of restless leg syndrome in patients with liver cirrhosis in India. Indian J Gastroenterol. 2016 ;35(3):216-21.
    77. Aggarwal R, Goel A. Advances in hepatitis E - I: Virology, pathogenesis and diagnosis. Expert Rev Gastroenterol Hepatol. 2016; 10(9):1053-63.
    78. Goel A, Aggarwal R. Advances in hepatitis E- II: Epidemiology, clinical manifestations, treatment and prevention. Expert Rev Gastroenterol Hepatol. 2016; 10(9):1065-74.
    79. Yadav S, Goel A, A Saraswat V, A Thomas M, Wang E, M Marincola F, Haris M, K Gupta R. Evaluation of cognitivity, proinflammatory cytokines, and brain MRI in minimal hepatic encephalopathy induced by cirrhosis and EHPVO. J Gastroenterol Hepatol. 2016;31(12):1986-1994.
    80. Goel A, Aggarwal A, Aggarwal R. Hepatitis B vaccine: Using skin when muscle does not work. J Gastroenterol Hepatol 2016; 31: 524-526.
    81. Goel A, Lakshmi CP, Bakshi SS, Soni N, Koshy S. Single-center prospective study of Plummer-Vinson syndrome. Dis Esophagus. 2016; 29 (7):837-841.
    82. Petrik J, Lozano M, Seed CR, Faddy HM, Keller AJ, Prado Scuracchio PS, Wendel S, Andonov A, Fearon M, Delage G, Zhang J, Shih JW, Gallian P, Djoudi R, Tiberghien P, Izopet J, Dreier J, Vollmer T, Knabbe C, Aggarwal R, Goel A, Ciccaglione AR, Matsubayashi K, Satake M, Tadokoro K, Jeong SH, Zaaijer HL, Zhiburt E, Chay J, Teo D, Chua SS, Piron M, Sauleda S, Echevarría JM, Dalton H, Stramer SL. Hepatitis E. Vox Sang 2016; 110: 93-103.
    83. Aggarwal R, Goel A. Screening transfusions for hepatitis E virus: Is it needed in India? Natl Med J India 2015; 28: 217-19.
    84. Goel A. The challenge of drug induced liver injury (Falk Workshop) and challenges and management of liver cirrhosis (Falk Symposium 195). Natl Med J India 2015; 28: 258.
    85. Aggarwal R, Goel A. Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis 2015; 28: 488-96.
    86. Naik A, Goel A, Agrawal V, Sarangi AN, Chhavi N, Singh V, Jameel S, Aggarwal R. Changes in gene expression in liver tissue from patients with fulminant hepatitis E. World J Gastroenterol 2015; 21: 8032-42
    87. Jat SL, Gupta N, Kumar T, Mishra S, S A, Yadav V, Goel A, Aggarwal R. Prevalence of hepatitis D virus infection among hepatitis B virus-infected individuals in India. Indian J Gastroenterol 2015; 34: 164-8.
    88. Bhadauria D, Goel A, Kaul A, Sharma RK, Gupta A, Ruhela V, Gupta A, Vardhan H, Prasad N. Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis. 2015 Feb; 17(1): 48-55.
    89. Munjal S, Gupta N, Sharma RK, Gupta A, Prasad N, Kaul A, Bhadauria D, Goel A, Aggarwal R. Lack of persistent hepatitis E virus infection as a cause for unexplained transaminase elevation in renal transplant recipients in India. Indian J Gastroenterol 2014; 33: 550-3.
    90. Chhavi N, Zutshi K, Singh NK, Awasthi A, Goel A. Serum liver enzyme pattern in birth asphyxia associated liver injury. Pediatr Gastroenterol Hepatol Nutr 2014; 17: 162-9.
    91. Goel A, Gupta M, Aggarwal R. Gut microbiota and liver disease. J Gastroenterol Hepatol 2014; 29: 1139-48.
    92. Lakshmi CP, Goel A, Basu D. Cholestatic presentation of yellow phosphorus poisoning. J Pharmacol Pharmacother 2014; 5: 68-70.
    93. Goel A, Aggarwal R. Unconjugated hyperbilirubinemia: a blessing in disguise? J Gastroenterol Hepatol 2013; 28: 1687-9.
    94. Goel A, Lakshmi CP, Pottakkat B. Biliary ascariasis: Mimicker of retained bile duct stone. Dig Endosc 2012; 24:480.
    95. Agrawal V, Goel A, Rawat A, Naik S, Aggarwal R. Histological and immunohisto­chemical features in fatal acute fulminant hepatitis E. Indian J Pathol Microbiol 2012; 55: 22-7.
    96. Ghoshal UC, Goel A, Ghoshal U, Jain M, Misra A, Choudhuri G. Chronic diarrhea and malabsorption due to hypogammaglobulinemia: a report on twelve patients. Indian J Gastroenterol 2011; 30: 170-4.
    97. Goel A, Aggarwal R. Hepatitis E: another effective vaccine, but will it make a difference? Natl Med J India 2011; 24: 30-2.
    98. Goel A, Aggarwal R. Prevention of hepatitis E: another step forward. Future Microbiol 2011; 6: 23-7.
    99. Goel A, Yadav SK, Saraswat VA, Srivastava A, M David Thomas, Pandey CM, Gupta RK, Rathore RK. Cerebral oedema in minimal hepatic encephalopathy due to extrahepatic portal venous obstruction. Liver Int 2010; 30: 1143-51.
    100. Lakshmi CP, Ghoshal UC, Kumar S, Goel A, Misra A, Mohindra S, Choudhuri G. Frequency and factors associated with small intestinal bacterial overgrowth in patients with cirrhosis of the liver and extra hepatic portal venous obstruction. Dig Dis Sci 2010; 55: 1142-8.
    101. Yachha SK, Goel A, Khanna V, Poddar U, Srivastava A, Singh U. Ascitic form of sporadic acute viral hepatitis in children: a distinct entity for recognition. J Pediatr Gastroenterol Nutr 2010; 50: 184-7.
    102. Aggarwal R, Goel A. Control of hepatitis B and C worldwide. BMJ 2009; 339: b4431.
    103. Choudhuri G, Lakshmi CP, Goel A. Pancreatic diabetes. Trop Gastroenterol 2009; 30: 71-5.

    Book chapters

    1. Goel A, Chhavi N. Viral hepatitis. In: Postgraduate Textbook of Pediatrics; Editors, R Lodha, S Ramji, PSN Menon, P Gupta; First edition, 2015; JayPee Publishers; New Delhi; India.
    2. Goel A, Chhavi N. Viral hepatitis. In: Postgraduate Textbook of Pediatrics; Editors, R Lodha, S Ramji, PSN Menon, P Gupta; Second edition, 2017; JayPee Publishers; New Delhi; India
    3. Aggarwal R, Goel A. Liver Disorders. In: Principles and Practices of Geriatric Medicine. Editor; OP Sharma; First edition, 2015; Viva books private limited; New Delhi, India.
    4. Aggarwal R, Goel A. Hepatitis A virus. In: Liu D, Editor. Handbook of Food borne Diseases. First Edition. Taylor and Francis CRC Press. 2019
    5. Goel A. The liver in systemic diseases. In. API Textbook of Medicine. 11th Sandhya A Kamath, Editor-in-chief. CBS Publisher & Distributors Pvr Ltd. 2019
    6. Kumar A, Tiwari S, Goel A. Management of Inflammatory Bowel Disease (IBD) by Probiotics Biofilms. In: Kumar S., Chandra N., Singh L., Hashmi M., Varma A. (eds) Biofilms in Human Diseases: Treatment and Control. Springer, Cham 2019
    7. Goel A, Aggarwal R. Hepatitis E virus vaccines: have they arrived - when, where and for whom? In: Clinical Dilemmas in Viral Liver Disease; Editors, KR Reddy, GR Foster; Second edition 2020; Wiley-Blackwell Publisher; USA
    8. Goel A. Liver in systemic disease. In API Textbook of Medicine.